Abbott Laboratories (NYSE:ABT) Given New $124.00 Price Target at Evercore ISI
Abbott Laboratories (NYSE:ABT – Free Report) had its price objective increased by Evercore ISI from $120.00 to $124.00 in a research note published on Tuesday, Benzinga reports. Evercore ISI currently has an outperform rating on the healthcare product maker’s stock. Other equities analysts have also issued reports about the stock. Piper Sandler Companies assumed coverage […]
5 Oct 17:11 · The Cerbat Gem